Scott Michael Galovan - 06 Mar 2026 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, Chief Financial Officer
Signature
/s/ John S. Fischer, as attorney-in-fact for Scott M. Galovan
Issuer symbol
AVNS
Transactions as of
06 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 09:48:37 UTC
Previous filing
22 Aug 2025
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Galovan Scott Michael SVP, Chief Financial Officer 5405 WINDWARD PARKWAY, SUITE 100, ALPHARETTA /s/ John S. Fischer, as attorney-in-fact for Scott M. Galovan 10 Mar 2026 0002082926

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Options Exercise +5,907 +5.3% $13.79* 116,916 06 Mar 2026 Direct F1
transaction AVNS Common Stock Tax liability -2,356 -2% $13.79* 114,560 06 Mar 2026 Direct F2
transaction AVNS Common Stock Tax liability -1,057 -0.92% $13.79* 113,503 06 Mar 2026 Direct F3
transaction AVNS Common Stock Tax liability -2,041 -1.8% $13.79* 111,462 06 Mar 2026 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each PRSU is the economic eqiuvalent of one share of Common Stock.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,907 PRSUs which vested on March 6, 2026.
F3 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 2,649 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.
F4 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,172 TRSUs which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.